Document
Drug-Induced Cardiotoxicity (e.g., Chemotherapy) Banner

Drug-Induced Cardiotoxicity (e.g., Chemotherapy)

About Drug-Induced Cardiotoxicity (e.g., Chemotherapy)

Drug-induced cardiotoxicity refers to heart damage caused by certain medications, particularly chemotherapy drugs, targeted cancer therapies, and some long-term medications. The condition may affect heart muscle function, electrical activity, heart v...

Overview

Common causes of cardiotoxicity include: Chemotherapy agents Radiation therapy Certain antibiotics Immunotherapy drugs Recreational drug toxicity Cardiotoxicity may lead to: Heart failure Arrhythmias Hypertension Myocarditis Reduced heart pumping function Diagnostic evaluation may include: Echocardiography ECG Cardiac biomarkers Cardiac MRI Blood pressure monitoring Cardio-oncology teams often coordinate care between cardiologists and oncologists. Treatment may involve medication adjustment, heart failure management, and long-term cardiac monitoring.

Understanding The Procedure

Symptoms Drug-Induced Cardiotoxicity (e.g., Chemotherapy)

  • Breathlessness
  • Fatigue or weakness
  • Swelling of legs
  • Chest discomfort
  • Palpitations or dizziness

Risks

  • Heart failure
  • Permanent cardiac muscle damage
  • Arrhythmias
  • Reduced tolerance to cancer therapy
  • Sudden cardiac complications in severe cases

Post-Operative Care

  • Attend regular cardiac screening appointments
  • Continue medications as prescribed
  • Monitor blood pressure and heart symptoms carefully
  • Maintain healthy nutrition and physical activity
  • Inform doctors about worsening fatigue or breathlessness

Long Term Outlook

Early monitoring and intervention can reduce long-term cardiac complications and improve overall survival and quality of life in patients receiving potentially cardiotoxic treatments.

Prefer WhatsApp for Drug-Induced Cardiotoxicity (e.g., Chemotherapy) enquiries? We respond on chat during working hours.

Book An Appointment